631 filings
Page 13 of 32
8-K
gm322pcrqef0
6 May 14
BioDelivery Sciences Announces Randomization of Over 50% of Subjects
12:00am
8-K
n62q85
3 Apr 14
BioDelivery Sciences Announces Enrollment of the First Patient in a Phase 3 Clinical Study of
12:00am
8-K
dpmafy 5be
27 Mar 14
BioDelivery Sciences Announces Commercialization Agreement with Quintiles to Support
12:00am
8-K
crj4fz
14 Mar 14
BioDelivery Sciences Provides Business Review and Update
12:00am
8-K
vzgta8yx5egl7ol3t 36
14 Feb 14
BioDelivery Sciences Closes $60 Million Registered Direct Offering
12:00am
8-K
tp2ww 4mo
10 Feb 14
Proceeds support BDSI’s complete execution of anticipated 2014 commercial launch plans for BUNAVAIL™ and funding of Clonidine Topical Gel NDA program
12:00am
424B5
602flkeb c2oyud
10 Feb 14
Prospectus supplement for primary offering
12:00am
8-K
17tcn5c2vb0gmn
24 Jan 14
Other Events
12:00am
8-K
mp5isif2c 26
10 Jan 14
BioDelivery Sciences Provides an Update of Anticipated 2014 Milestones
12:00am
CORRESP
6mft3sp
18 Dec 13
Correspondence with SEC
12:00am
EFFECT
9qji7 9hdcd2n594
18 Dec 13
Notice of effectiveness
12:00am
UPLOAD
s6aa9724 6mc
12 Dec 13
Letter from SEC
12:00am
8-K
5yqs1trrsqtdsm
2 Dec 13
Other Events
12:00am
8-K
3v7ffujoix9ff d3gsk
13 Nov 13
BioDelivery Sciences Provides Business Review and Update
12:00am
CT ORDER
8tid1t7q3i0ewih
24 Oct 13
Confidential treatment order
12:00am
8-K
m3ccrx7octv
23 Oct 13
BioDelivery Sciences Appoints Ernest De Paolantonio
12:00am